Health management business wins Cambridge investment
Healthera, a provider of next-generation, pharmacy-integrated personal health management solutions, has secured seed investment from the University of Cambridge, the University of Cambridge Enterprise Fund III, FT Capital and high net worth individuals. The specific amounts are undisclosed.
This round of institutional funding allows Healthera to complete its product development on the next generation of pharmacy IT solutions and personal health management app, and it has financed its pre-launch testing of product-market fit.
Healthera’s products seamlessly transfer and interpret complex medical instructions to patients; empower the pharmacy industry with digital technology, helping it cut costs and develop multiple additional revenue streams, despite the recent government austerity; and enable patients to participate in managing their own medication and supply their healthcare providers with real-world analytics.
In January, Healthera became the first pharmacy-integrated medication-application available on the Apple app store. Cambridge Enterprise Investment Manager Tania Balsa joins the board along with Martijn Veltmaat, a veteran CEO in the healthcare technology space.
Managing director Martin Hao said: “The funds raised have enabled Healthera to grow from a small startup to a structured technology company with its own culture. We have built strong technical and commercial teams, established strategic partnerships in the industry and won NHS contracts.”
Quintus Liu, Chairman and CEO of Healthera, added: “The NHS needs a transformative solution to medical non-adherence that can be easily scaled to its entire population.
“That’s exactly what Healthera provides. We’re also the first to turn pharmacies, the traditional centre of primary care, into digital innovators in serving their patients effectively.”